Zebra Medical Vision (Nanox AI)

Nanox AI, formerly known as Zebra Medical Vision before its strategic acquisition by Nano-X Imaging Ltd., is a pioneering medical technology company that builds advanced artificial intelligence algorithms for clinical radiology. The platform specializes in automated incidental findings detection, which means it analyzes standard, routine CT scans that have already been ordered for other clinical indications to uncover hidden chronic conditions. By acting as an automated second opinion within existing hospital data systems, the software flags asymptomatic or completely undetected health risks, allowing clinical teams to step in early with preventative care management protocols.

The Nanox AI clinical portfolio is built around a comprehensive suite of FDA-cleared and CE-marked algorithms targeting widespread, highly critical health conditions in three primary areas: cardiac, bone, and liver health. Its flagship cardiac solution, HealthCCSng, automatically detects coronary artery calcification (CAC) on non-gated CT scans to catch early signs of coronary artery disease. The bone solution, HealthOST, analyzes chest and abdominal CT scans to measure bone mineral density and flag hidden vertebral fractures caused by osteoporosis, while the liver solution, HealthFLD, delivers automated liver density measurements to assist in the early detection of hepatic steatosis (fatty liver disease).

The Nanox AI software architecture is completely vendor-agnostic and designed to deploy smoothly inside an institution's existing digital ecosystem without forcing staff to learn a new interface. It links natively with popular Picture Archiving and Communication Systems (PACS), Electronic Medical Records (EMR), and radiology reporting systems via secure cloud infrastructure. Beyond traditional CT systems, this AI suite is a core component of next-generation digital radiography hardware, including the multi-source 3D tomosynthesis systems Nanox.ARC and Nanox.ARC X, allowing for a unified approach to high-precision imaging and rapid automated clinical interpretation.

Implementing Nanox AI transforms radiology departments from reactive diagnostics to proactive population health management, generating substantial improvements in both patient outcomes and institutional revenue. Real-world clinical evidence shows that utilizing the platform dramatically boosts chronic disease identification rates; for instance, health systems adopting the cardiac solution reported identifying thousands of new patients with critical coronary calcification compared to traditional baseline reporting methods. Financially, by uncovering these hidden, high-risk conditions from scans that have already been performed, the platform generates a powerful return on investment (ROI) by feeding necessary clinical follow-ups, diagnostic workups, and targeted preventative treatments directly back into the healthcare network.